Effects of low doses of hydrochloride tetracycline on bone metabolism and uterus in ovariectomized rats

Acta Pharmacologica Sinica

Volumn 24, Issue 6, 2003, Pages 599-604+623

  Li, Qing Nan ^a,b   Hu, Bin ^c   Huang, Lian Fang ^c   Chen, Yan ^c   Weng, Ling Ling ^b   Zheng, Hu ^b   Chen, Huai Qing ^b  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c NONE

Author keywords

Metabolic bone diseases; Ovariectomy; Tetracycline; Tibia; Uterus

Indexed keywords

CALCEIN; CHELATING AGENT; ESTRONE; LACTOSE; PARAFFIN; PLACEBO; TETRACYCLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MASS; BONE METABOLISM; BONE TURNOVER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENDOMETRIUM ATROPHY; FEMALE; LIVER TOXICITY; METAPHYSIS; MORPHOMETRICS; NEPHROTOXICITY; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; OVARIECTOMY; QUANTITATIVE ANALYSIS; RAT; TIBIA; TRABECULAR BONE;

ANIMALS; BONE RESORPTION; ESTRONE; FEMALE; ORGAN SIZE; OVARIECTOMY; PROTEIN SYNTHESIS INHIBITORS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TETRACYCLINE; TIBIA; UTERUS;

EID: 0038170394     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Li QN, Jee WSS, Ma YF, Ke HZ, Xie H, Huang LF, et al. Risedronate pretreatment does not hamper the anabolic effects of prostaglandin E2 in OVX rats. Bone (Suppl) 1995;17:261s-6s.
2. Sun TC, Mori S, Roper J, Brown C, Hooser T, Burr DB. Do different fluorochrome labels give equivalent histomorphometric information? Bone 1992;13:443-6.
3. Lin BY, Jee WSS, Ma YF, Ke HZ, Kimmel DB, Li XJ. Effects of prostaglandin E2 and risedronate administration on cancellous bone in older female rats. Bone 1994;15:489-96.
4. Hattner RS, Ilnicki LP, Hodge HC. The dose-response relationship of tetracycline to the detectability of labeled osteons by fluorescence microscopy. New York: deGruyter; 1977. p 377-80.
5. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA. Bone histomorphometry nomenclature, symbols and units. J Bone Min Res 1987;2:596-610.
6. Jee WSS, Inoue J, Jee KW, Haba T. Histomorphometric assay of the growing long bone. In: Takahashi H, editor. Handbook of bone morphology. Japan: Niigata city; 1983. p 101-22.
7. Li QN, Liang NC, Huang LF, Wu T, Hu B, Mo LR. Skeletal effcts of constant and terminated use of sodium risedronate in ovariectomized rats. Acta Pharmacol Sin 1998;19:160-3.
8. Li QN, Liang NC, Huang LF, Wu T, Hu B, Mo LE. Skeletal effects of constant and terminated use of risedronate on cortical bone in ovx rats. J Bone Miner Metab 1999;17:18-22.
9. Wronski TJ, Yen CF, Qi H, Dann LM. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Endocrinology 1993;132:823-30.
10. Bettany JT, Peet NM, Wolowacz RG, Skerry TM, Grabowski PS. Tetracyclines induce apoptosis in osteoclasts. Bone 2000;27:75-80.
11. Sasaki T, Ohyori N, Debari K, Ramamurthy NS, Golub LM. Effects of chemically modified tetracycline, CMT-8, on bone loss and structure and function in osteoporotic states. Ann N Y Acad Sci 1999;878:347-60.